Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
The knee pain is all but gone
These findings highlight the importance of maintaining continuous GLP-1 treatment to sustain cardiovascular benefits and indicate that strategies to reduce treatment discontinuity should be developed to maximize the cardioprotective effects of GLP-1s
At this dose, she has been able to reduce her insulin needs, maintain weight stability, and feel more confident in her diabetes self-management plan
These medicines were invented as an alternative way to treat type 2 diabetes because of the drugs capabilities to regulate blood sugar levels and control appetite
[6] Meanwhile, the kidneys were quietly rewriting their own chapter